Ribbon Bio’s CEO, Jodi Barrientos, and CTO, Dr. John Luckey, will be attending the 2025 J.P. Morgan Healthcare Conference, January 13-16.
Reach out to set up a meeting and discover how Ribbon Bio utilizes its algorithm-driven technology to offer synthetic DNA molecules of unrivalled length, complexity, and accuracy to enable our partners make the impossible possible.
